Page 355 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 355

340    SECTION II  Diseases of Organ Systems


                         (f)  The North American type preferentially involves the abdomen (bowel, retroperito-
                           neum and ovaries).
                         (g)  Tumour cells are uniform with round to oval nuclei (approximately, the size of
                           nuclei  of  macrophages),  2–5  nucleoli  and  moderate  amount  of  basophilic  or
                           amphophilic cytoplasm.
                          (h)  Neoplasm characterized by a high mitotic rate and cell death leading to the pres-
                           ence  of  numerous  macrophages  with  debris.  These  macrophages  are  often
                           surrounded by a clear space creating a characteristic ‘starry sky’ appearance.
                         (i)  Tumour cells express surface IgM, kappa and lambda light chains and pan B-cell
                           markers (CD19, CD20 and CD10).
                         (j)  Chromosome analysis may show 8; 14 or 2; 8 or 8; 22 translocations. Most trans-
                           locations fuse MYC with IgH gene on chromosome 14 resulting in dysregulation
                           and overexpression of MYC protein.
                         (k)  Antibodies to EB viral capsid antigen may be present.
                       6.  Mucosa-associated lymphoid tissue (MALT) lymphoma (extranodal marginal zone
                        lymphoma)
                         (a)  Low-grade  mature  B-cell  tumour  that  arises  from  mucosa-associated  lymphoid
                           tissue (MALT).
                         (b)  Seen in salivary glands, stomach, small and large bowel, lungs, orbit and breast.
                         (c)  Gastric type of MALT lymphoma is associated with Helicobacter	pylori infection.
                           Salivary  gland  MALT  is  associated  with  Sjögren  syndrome  indicating  sustained
                           antigenic stimulation may contribute to development of these lymphomas.
                          (d)  It is mainly seen in elderly patients with median age of 60 years.
                         (e)  MALT lymphomas may remain localized to the organ from which they arise or may
                           spread to the surrounding lymph nodes.
                         (f)  Bone marrow involvement is uncommon and occurs in only 15% cases. Distant
                           metastasis is possible.
                         (g)  Prognosis is good in most cases (5-year survival of 75%).

                     Common Mature Peripheral T-Cell Malignancies
                       1.  Mycosis fungoides and Sézary syndrome
                         (a)  Cutaneous T-cell lymphomas composed of neoplastic CD41 T cells that home to
                           the skin.
                         (b)  The patient presents with chronic erythrodermic rash manifesting as a localized
                           plaque-like  lesion  (plaque  phase)  which  later  becomes  nodular  and  ulcerated
                           (tumour phase).
                         (c)  Histological  findings  include  infiltration  of  the  epidermis  and  upper  dermis  by
                           neoplastic  T  cells,  which  have  a  cerebriform  nucleus  characterized  by  marked
                           infolding of the nuclear membrane.
                          (d)  In  some  cases,  a  leukaemic  phase  called  Sézary  syndrome  appears,  which  is
                           characterized by:
                            (i)  Generalized exfoliative erythroderma
                             (ii)  Tumour cells in the peripheral blood
                         (e)  Patients with erythrodermic phase of mycosis fungoides usually survive for many
                           years; survival less (1–3 years) for patients in tumour phase of the disease, visceral
                           disease and Sézary syndrome.
                       2.  Adult T-cell lymphoma/leukaemia
                         (a)  Caused by a retrovirus, human T-cell lymphotropic virus-I (HTLV-I)
                         (b)  Patients  are  infected  through  transplacental  transmission,  blood  transfusion  or
                           sexual contact.
                         (c)  Most  patients  have  an  aggressive  disease  characterized  by  lymphadenopathy,
                           hepatosplenomegaly, skin infiltration, hypocalcaemia and lytic bone lesions.
                         (d)  Peripheral smear usually reveals characteristic, pleomorphic abnormal CD4-positive
                           cells with indented nuclei.
                         (e)  Leukaemic cells express high levels of CD25 (The IL2 receptor a chain).
                         (f)  Extremely aggressive disease with a median survival of 8 months. A few patients
                           have long, chronic course.
                         (g)  Combination chemotherapy may prolong life but does not produce remissions.


                                  mebooksfree.com
   350   351   352   353   354   355   356   357   358   359   360